Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 1/20 | 0.44 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.39 |
| ▸ | BRD4 | O60885 | 3/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | DRD3 | P35462 | 2/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5247618 | 0.97 | SMPD1 (0.43) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5244720 | 0.92 | KMT2A (0.43) | SMPD1 | |
| SCHEMBL5243860 | 0.92 | SMPD1 (0.42) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5244569 | 0.92 | SMPD1 (0.41) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5245521 | 0.91 | SMPD1 (0.41) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5244512 | 0.91 | SMPD1 (0.42) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5246108 | 0.90 | BRD4 (0.47) | BRD4CNR2DRD2DRD3 | |
| SCHEMBL5245729 | 0.90 | SMPD1 (0.40) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5247137 | 0.90 | SMPD1 (0.40) | SMPD1ACKR3BRD4CNR2TP53 | |
| SCHEMBL5246678 | 0.90 | SMPD1 (0.39) | SMPD1ACKR3BRD4DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1867331-A1 | TRIAZOLE DERIVATIVE AND THE USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2007-12-19 | — | — | EP | disclosed |